Source: Annual Congress 2005 - COPD - treatment I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Lores, M. Palau, F. Andreo, X. Casas, C. Plans (Sant Boi, Viladecans, Spain). Sertraline effects on dyspnea in patients with severe COPD. Eur Respir J 2005; 26: Suppl. 49, 1925

Member's Comments

No comment yet.

Related content which might interest you: Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Prolonged effect of exacerbations on fatigue and depression in moderate clinically stable COPD Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Respiratory depression secondary to morphine use in a patient with COPD and refractory breathlessness Source: Eur Respir J, 49 (5) 1601858; 10.1183/13993003.01858-2016 Year: 2017 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD Source: Eur Respir J 2013; 41: 993-995 Year: 2013 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Siccine acid effects in patients with exacerbation of severe COPD Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Two-year safety of targeted lung denervation in patients with moderate to severe COPD Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more Year: 2015 Impact of exacerbation of COPD on anxiety and depression symptoms and dyspnea in the activities of daily living Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD Year: 2015 The efficacy and side-effects of varenicline in patients with mild to moderate chronic obstructive pulmonary diseases Source: Annual Congress 2010 - Passive smoking Year: 2010 Budesonide/formoterol in a single inhaler reduces severe and mild exacerbations in patients with moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 242s Year: 2002 Once-daily glycopyrronium improves lung function and reduces exacerbations in severe-to-very severe COPD patients: The SPARK study Source: Annual Congress 2013 –New bronchodilators for COPD management Year: 2013 GERD and anxiety in patients with severe COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Mechanisms of exacerbation of respiratory symptoms in patients with CHF Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Drivers of respiratory symptoms in COPD patients Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Cognitive impairment in patients hospitalized with acute COPD exacerbation Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma Year: 2014 Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 Gender differences in exertional breathlessness in patients with mild COPD Source: Annual Congress 2007 - Advances in respiratory muscles Year: 2007